About this tool
The Lansky Play-Performance Scale measures how well a child aged 1 to 16 years with cancer or another serious illness is functioning, by rating play and activity from 100 (fully active, normal) to 0 (unresponsive). It is the pediatric version of the adult Karnofsky scale and the usual performance score in pediatric oncology trials.
Confirm the child is under 16 (from 16 years, use the Karnofsky scale), then ask the parent about a usual day over the past week and pick the line that fits best: from minor limits on strenuous play (90), through less active play and more quiet play (50–70), to mostly in bed (40 and below).
The result explains the level, gives a rough ECOG equivalent, notes the usual trial threshold (often 50 or more), and lists next steps: looking for treatable causes such as pain, anaemia, infection, poor nutrition or low mood, therapy and school support, palliative care involvement when the score stays low, and urgent review for a sudden fall. Source: Lansky et al., Cancer 1987.
Common questions
What is a normal Lansky score?
100 is fully active and normal. In the original study, healthy children averaged 98, outpatients on cancer treatment 91 and inpatients 42.
What Lansky score is needed for clinical trials?
Many pediatric oncology trials require a Lansky score of 50 or more for children under 16; some phase 1 or 2 trials ask for 60 or 70. Always check the protocol.
Lansky or Karnofsky: which scale should I use?
Use Lansky for children 1 to 16 years; it rates play. From 16 years, use Karnofsky, which rates work and self-care. Protocols usually state the age cut-off.
Who should rate the Lansky score?
It was designed to be rated with a parent, about the child's usual play over the past week. Record who gave the rating and use the same rater over time if you can.